Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BTV-8 re-emerging in northern Europe, APHA warns
Owing to the weaker pathogenicity of the re-emerging strain, there may be fewer clinical signs than the 2007 strain.
Weaker pathogenicity means clinical signs may be fewer 

Vets are being reminded of the risk of bluetongue virus, as serotype 8 re-emerges in northern Europe.

According to an APHA briefing, there have been reports from France of calves being born small and blind, dying at just a few days old, since mid-December 2018. There has been a considerable increase in reports since January this year.

The affected animals have been positive by PCR on blood and spleen for BTV-8. APHA said the detection of BTV-8 in calves of around a week old, during the culicoides vector-free period, suggests transplacental infection.

Since the first reports of cases, 418 samples have tested positive for BTV-8 by PCR, with between two and 15 per cent of newborn calves affected on some farms.

Further studies using experimental midge infection suggest that the current BTV-8 strain in France has a reduced culicoides vector competence.

Official veterinarians are being urged to consider BTV-8 as a possible cause of malformed calves or abortion, and to be aware that the re-emerging strain in northern Europe could cause transplacental transmission and infection of foetuses in cattle.

Owing to the weaker pathogenicity of the re-emerging strain, there may be fewer clinical signs than the 2007 strain, so APHA says an increase in awareness is important.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.